Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 8851-8900 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07161232
The Influence of the Timing of Postoperative Rehabilitation Intervention on the Clinical Efficacy of Unilateral Biportal Endoscopic Spine System in the Treatment of Lumbar Disc Herniation
NARecruiting
72 participants
Started: Mar 28, 2025 · Completed: Mar 28, 2027
2 conditions1 sponsor1 location
NCT06632496
BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study
N/ARecruiting
149 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06898203
Precision Imaging to Evaluate Kaposi Sarcoma
NARecruiting
100 participants
Started: Mar 28, 2025 · Completed: Nov 30, 2029
1 condition5 sponsors2 locations
NCT06882746
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
PHASE1Recruiting
135 participants
Started: Mar 28, 2025 · Completed: May 12, 2027
3 conditions1 sponsor3 locations
NCT07152041
Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
PHASE3Recruiting
150 participants
Started: Mar 28, 2025 · Completed: Jun 30, 2030
2 conditions1 sponsor24 locations
NCT06867094
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
PHASE2Recruiting
204 participants
Started: Mar 28, 2025 · Completed: May 11, 2028
1 condition1 sponsor83 locations
NCT06897475
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
PHASE2Recruiting
240 participants
Started: Mar 28, 2025 · Completed: Jan 31, 2027
1 condition1 sponsor56 locations
NCT06928545
MagDI U.S. Registry
N/ARecruiting
106 participants
Started: Mar 28, 2025 · Completed: Apr 30, 2027
3 conditions1 sponsor3 locations
NCT06915012
Impact of Biophoton Therapy on Chronic Severe Arthritis Pain
NARecruiting
102 participants
Started: Mar 28, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT07147660
Vision on the Road: Vision Rehabilitation for Driving After Stroke
NARecruiting
52 participants
Started: Mar 28, 2025 · Completed: Feb 29, 2028
3 conditions2 sponsors2 locations
NCT06800430
Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery
N/ARecruiting
70 participants
Started: Mar 28, 2025 · Completed: Aug 6, 2027
4 conditions2 sponsors1 location
NCT06840860
Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)
N/ARecruiting
1,000 participants
Started: Mar 28, 2025 · Completed: Feb 28, 2027
1 condition9 sponsors2 locations
NCT06827327
LC-Plasma for Preventing URTIs and Reducing Symptoms
PHASE3Recruiting
650 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06914375
Effect of Lentils and Chickpeas on Gut Microbiome and Metabolic Health
NARecruiting
60 participants
Started: Mar 28, 2025 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06880653
Dose Response of Exercise for Arthritis Management
NARecruiting
285 participants
Started: Mar 28, 2025 · Completed: Apr 30, 2029
6 conditions2 sponsors1 location
NCT06913296
PTeye in Parathyroid Adenoma
N/ARecruiting
50 participants
Started: Mar 28, 2025 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT06761287
Optimizing Patient Selection for Surgery Using Pathologic Analysis Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NARecruiting
20 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06569667
Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
NARecruiting
292 participants
Started: Mar 28, 2025 · Completed: Aug 31, 2026
1 condition4 sponsors1 location
NCT06421675
Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma
PHASE2Recruiting
40 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2028
1 condition2 sponsors4 locations
NCT06408857
Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population
PHASE1Recruiting
123 participants
Started: Mar 28, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor2 locations
NCT06938087
Assessment of Safety and Performances of a 3D Printed Prosthetic Foot: A Pilot Study
NARecruiting
3 participants
Started: Mar 28, 2025 · Completed: Apr 17, 2025
1 condition3 sponsors1 location
NCT06620809
The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders
PHASE1Recruiting
69 participants
Started: Mar 28, 2025 · Completed: Nov 30, 2027
1 condition2 sponsors1 location
NCT06895928
A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors
PHASE2Recruiting
400 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06944106
A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
PHASE2Recruiting
30 participants
Started: Mar 28, 2025 · Completed: Mar 28, 2027
1 condition1 sponsor1 location
NCT06854653
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
PHASE2Recruiting
115 participants
Started: Mar 28, 2025 · Completed: Jun 30, 2028
1 condition1 sponsor16 locations
NCT06900816
A Comparison Study Between Adolescents With Asthma and Adults With Asthma on How They Absorb, Metabolise and Eliminate CHF 6001
PHASE2Recruiting
50 participants
Started: Mar 28, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06829537
Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)
N/ARecruiting
1,000 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2025
2 conditions1 sponsor46 locations
NCT06830759
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
N/ARecruiting
700 participants
Started: Mar 28, 2025 · Completed: Sep 30, 2031
2 conditions2 sponsors39 locations
NCT06573749
Effect of 12-week Milk Fat Globule Membrane Supplementation on the Human Muscle Function of Healthy, Recreationally Active Adults
NARecruiting
96 participants
Started: Mar 28, 2025 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT06718413
Myofascial Dysfunction in Post Stroke Shoulder Pain
PHASE2Recruiting
68 participants
Started: Mar 28, 2025 · Completed: Aug 31, 2028
1 condition2 sponsors1 location
NCT06691893
Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients
PHASE3Recruiting
60 participants
Started: Mar 28, 2025 · Completed: Jul 15, 2027
2 conditions2 sponsors1 location
NCT06630884
Inflammatory Challenge and Fear
PHASE1Recruiting
288 participants
Started: Mar 28, 2025 · Completed: Nov 30, 2028
1 condition4 sponsors1 location
NCT06869187
Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults
PHASE2Recruiting
35 participants
Started: Mar 28, 2025 · Completed: Mar 13, 2026
1 condition1 sponsor11 locations
NCT06834230
Effect of Dotinurad in Hyperuricemia With Hypertension
PHASE4Recruiting
360 participants
Started: Mar 28, 2025 · Completed: Mar 31, 2030
2 conditions1 sponsor1 location
NCT06909357
Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients
NARecruiting
90 participants
Started: Mar 28, 2025 · Completed: Mar 31, 2026
1 condition2 sponsors3 locations
NCT06624371
Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
PHASE1Recruiting
18 participants
Started: Mar 28, 2025 · Completed: Oct 31, 2027
4 conditions2 sponsors2 locations
NCT06889389
Effects of Education and Exercise on Pain, Psychosocial Factors, and Upper Limb Function in Non-specific Neck Pain.
NARecruiting
81 participants
Started: Mar 28, 2025 · Completed: Jan 30, 2026
5 conditions1 sponsor1 location
NCT06750289
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
PHASE3Recruiting
400 participants
Started: Mar 28, 2025 · Completed: Nov 2, 2027
1 condition1 sponsor131 locations
NCT06443606
Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy
PHASE3Recruiting
108 participants
Started: Mar 27, 2025 · Completed: Jun 1, 2029
2 conditions1 sponsor1 location
NCT06743269
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
NARecruiting
30 participants
Started: Mar 27, 2025 · Completed: Jan 31, 2027
3 conditions1 sponsor1 location
NCT06029491
The Pivotal Study of RapidPulseTM Aspiration System
NARecruiting
170 participants
Started: Mar 27, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor30 locations
NCT06971016
"Effectiveness of Mulligan Mobilization Technique and Proprioceptive Exercises Among Patients With Knee Osteoarthritis"
NARecruiting
60 participants
Started: Mar 27, 2025 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06897644
Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.
PHASE3Recruiting
340 participants
Started: Mar 27, 2025 · Completed: Jan 1, 2030
1 condition2 sponsors28 locations
NCT06270303
Use of a Bone Substitute Material in the Surgical Therapy of Furcation Defects
NARecruiting
200 participants
Started: Mar 27, 2025 · Completed: Mar 1, 2037
2 conditions7 sponsors1 location
NCT06923241
Nutri-score Labelling in a UK Restaurant Setting: a Randomised Control Trial
NARecruiting
450 participants
Started: Mar 27, 2025 · Completed: Aug 31, 2025
3 conditions3 sponsors1 location
NCT06644781
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
PHASE3Recruiting
510 participants
Started: Mar 27, 2025 · Completed: Nov 1, 2029
1 condition2 sponsors46 locations
NCT06647069
DR-0201 in Subjects With Autoimmune Diseases
PHASE1Recruiting
36 participants
Started: Mar 27, 2025 · Completed: Dec 31, 2026
12 conditions1 sponsor8 locations
NCT06890598
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
PHASE3Recruiting
700 participants
Started: Mar 27, 2025 · Completed: Feb 29, 2032
1 condition2 sponsors347 locations
NCT06618313
One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL
NARecruiting
8 participants
Started: Mar 27, 2025 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06744582
Estimating VO2 Max and Recovery
N/ARecruiting
30 participants
Started: Mar 27, 2025 · Completed: Apr 30, 2026
1 condition2 sponsors2 locations